GlassScriptPhysician profile
Stephen B Johnston
NPI 1831163153
$1,971.43
in general payments reported to CMS, 2019-2025
18 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $57.58 · 2021: $129 · 2023: $43.21 · 2024: $686 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $410.70 | 2023-2024 | Somatom Definition Flash |
| Heartflow, INC. | $318.89 | 2020-2024 | |
| Medtronic, INC. | $157.67 | 2025 | Symplicity G3 |
| Medtronic Vascular, INC. | $145.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $136.82 | 2019-2020 | |
| Novo Nordisk INC | $131.44 | 2025 | Wegovy, Ozempic, Rybelsus |
| Atricure, INC. | $125.27 | 2024 | |
| Novartis Pharmaceuticals Corporation | $111.52 | 2019-2025 | |
| Abbott Laboratories | $68.39 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $61.11 | 2019-2025 | |
| Glaxosmithkline, LLC. | $60.24 | 2024-2025 | Arexvy, Shingrix |
| Cleerly, INC. | $56.55 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Lilly USA, LLC | $52.35 | 2025 | Mounjaro, Zepbound |
| Amgen INC. | $31.98 | 2025 | Otezla, Repatha |
| Axsome Therapeutics, INC. | $29.35 | 2025 | Auvelity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $25.71 | 2019 | |
| Boston Scientific Corporation | $25.48 | 2024 | Watchman Access System |
| Exact Sciences Corporation | $22.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.